DiaMedica Therapeutics Inc. (DMAC) Annual Margin Report - Discounting Cash Flows
DMAC
DiaMedica Therapeutics Inc.
DMAC (NASDAQ)

Annual Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (Example: Net Income Margin = Net Income / Revenue).

This analysis provides a report of the company's key margins, which could be further used in a valuation model.

Interactive Assumptions

Historical Years

Historical Years

Number of historical years used to render the Chart and Tables.

Margin Analysis (% of Revenue)

Monetary values in USD

Monetary values in USD

amounts except #

Average LTM
Jan 11
2024
Dec 31
2023
Dec 31
2022
Dec 31
2021
Dec 31
2020
Dec 31
Revenue
0 0 0 0 0 0
Revenue Growth Rate
Cost of Revenue 0.005 0.029 0 0 0 0 0
Gross Profit -0.005 -0.029 0 0 0 0 0
Gross Margin
Operating Income -20.32 -33.6 -26.68 -21.27 -14 -13.65 -12.7
Operating Margin
Net Income -19.22 -31.93 -24.44 -19.38 -13.68 -13.59 -12.29
Net Margin

Monetary values in USD

amounts except #

Average LTM
Jan 11
2024
Dec 31
2023
Dec 31
2022
Dec 31
2021
Dec 31
2020
Dec 31
Revenue
0 0 0 0 0 0
Cash From Operating Activities Margin
Cash From Operating Activities -16.92 -27.79 -22.08 -18.73 -11.51 -12.25 -9.19
Free Cash Flow Margin
Free Cash Flow -16.96 -27.83 -22.1 -18.75 -11.59 -12.27 -9.23
Depreciation and Amortization Margin
Depreciation and Amortization 0.03 0.043 0.039 0.03 0.025 0.024 0.021
Capital Expenditure Margin
Capital Expenditure -0.04 -0.041 -0.025 -0.024 -0.081 -0.022 -0.047
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program